287 related articles for article (PubMed ID: 19718051)
21. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
Fassone L; Cingolani A; Martini M; Migliaretti G; Oreste PL; Capello D; Gloghini A; Vivenza D; Dolcetti R; Carbone A; Antinori A; Gaidano G; Larocca LM
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):19-26. PubMed ID: 11804553
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latent genes.
Kang MS; Kieff E
Exp Mol Med; 2015 Jan; 47(1):e131. PubMed ID: 25613728
[TBL] [Abstract][Full Text] [Related]
25. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
26. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.
Hagemeier SR; Barlow EA; Meng Q; Kenney SC
J Virol; 2012 Dec; 86(24):13360-70. PubMed ID: 23015717
[TBL] [Abstract][Full Text] [Related]
27. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
28. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
29. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
[TBL] [Abstract][Full Text] [Related]
30. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
31. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.
Chen F; Zou JZ; di Renzo L; Winberg G; Hu LF; Klein E; Klein G; Ernberg I
J Virol; 1995 Jun; 69(6):3752-8. PubMed ID: 7745723
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Epstein-Barr virus reactivation in a modeled spaceflight system.
Brinley AA; Theriot CA; Nelman-Gonzalez M; Crucian B; Stowe RP; Barrett AD; Pierson DL
J Cell Biochem; 2013 Mar; 114(3):616-24. PubMed ID: 22991253
[TBL] [Abstract][Full Text] [Related]
33. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.
Silins SL; Sculley TB
Int J Cancer; 1995 Jan; 60(1):65-72. PubMed ID: 7814154
[TBL] [Abstract][Full Text] [Related]
34. Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4.
Silins SL; Sculley TB
Virology; 1994 Jul; 202(1):16-24. PubMed ID: 8009829
[TBL] [Abstract][Full Text] [Related]
35. Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
Kelly GL; Stylianou J; Rasaiyaah J; Wei W; Thomas W; Croom-Carter D; Kohler C; Spang R; Woodman C; Kellam P; Rickinson AB; Bell AI
J Virol; 2013 Mar; 87(5):2882-94. PubMed ID: 23269792
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Kelly G; Bell A; Rickinson A
Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle.
Hau PM; Tsao SW
Viruses; 2017 Nov; 9(11):. PubMed ID: 29144413
[TBL] [Abstract][Full Text] [Related]
38. EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.
Gruhne B; Kamranvar SA; Masucci MG; Sompallae R
Semin Cancer Biol; 2009 Dec; 19(6):394-400. PubMed ID: 19619655
[TBL] [Abstract][Full Text] [Related]
39. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
40. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene.
Harada S; Yanagi K
Microbiol Immunol; 1992; 36(5):479-94. PubMed ID: 1325025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]